NYKREDIT MARKETS analysts reiterated a Buy rating on Novo Nordisk A/S (NYSE:NVO) on January 23, 2026.
Novo Nordisk A/S operates in the Healthcare sector. The stock currently trades at $60.33 with a market capitalization of $223.5B.
reiterateNYSE:NVO
NYKREDIT MARKETS Reiterates Buy Rating on Novo Nordisk A/S (NVO)
NYKREDIT MARKETS analysts reiterated a Buy rating on Novo Nordisk A/S (NYSE:NVO) on January 23, 2026. Novo Nordisk A/S operates in the Healthcare sector. The stock currently…
